Kronos Bio Inc

NASDAQ:KRON   12:29:45 PM EDT
26.05
+0.68 (+2.68%)
Earnings Announcements

Kronos Bio Posts Qtrly Loss Per Share $0.70

Published: 03/23/2021 21:18 GMT
Kronos Bio Inc (KRON) - Kronos Bio Reports Recent Business Progress and Fourth Quarter and Full Year 2020 Financial Results.
Qtrly Loss per Share $0.70.
Q4 Earnings per Share View $-0.79 -- Refinitiv Ibes Data (analyst estimates).
As of December 31, 2020, Cash, Cash Equivalents and Investments Totaled $462.1 Million.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.91

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.67

More details on our Analysts Page.